Phenotypic Effects of Biglycan Deficiency Are Linked to Collagen Fibril Abnormalities, Are Synergized by Decorin Deficiency, and Mimic Ehlers-Danlos-Like Changes in Bone and Other Connective Tissues

Oxford University Press (OUP) - Tập 17 Số 7 - Trang 1180-1189 - 2002
Alessandro Corsi1,2, Tianshun Xu3, Xiao‐Dong Chen3, A. Boyde4,2, Jingyao Liang3, Mahesh H. Mankani3, Beatrice Sommer3, Renato V. Iozzo5,2, Inge Eichstetter5,2, Pamela Gehron Robey3, P. Bianco6,2, Marian F. Young3
1Department of Experimental Medicine, Università dell'Aquila, L'Aquila, Italy
2National Institutes of Health, Bethesda
3Craniofacial and Skeletal Diseases Branch, National Institute of Craniofacial and Skeletal Diseases, National Institutes of Health, Bethesda, Maryland, USA
4Department of Anatomy and Developmental Biology, University College London, London, United Kingdom
5Department of Pathology, Anatomy and Cell Biology, Jefferson Medical College, Thomas Jefferson University, Philadelphia, Pennsylvania, USA
6Department of Experimental Medicine and Pathology, La Sapienza University, Rome, Italy

Tóm tắt

Abstract

Decorin (dcn) and biglycan (bgn), two members of the family of small leucine-rich proteoglycans (SLRPs), are the predominant proteoglycans expressed in skin and bone, respectively. Targeted disruption of the dcn gene results in skin laxity and fragility, whereas disruption of the bgn gene results in reduced skeletal growth and bone mass leading to generalized osteopenia, particularly in older animals. Here, we report that bgn deficiency leads to structural abnormality in collagen fibrils in bone, dermis, and tendon, and to a “subclinical” cutaneous phenotype with thinning of the dermis but without overt skin fragility. A comparative ultrastructural study of different tissues from bgn- and dcn-deficient mice revealed that bgn and dcn deficiency have similar effects on collagen fibril structure in the dermis but not in bone. Ultrastructural and phenotypic analysis of newly generated bgn/dcn double-knockout (KO) mice revealed that the effects of dcn and bgn deficiency are additive in the dermis and synergistic in bone. Severe skin fragility and marked osteopenia characterize the phenotype of double-KO animals in which progeroid changes are observed also in the skin. Ultrastructural analysis of bone collagen fibrils in bone of double-KO mice reveals a complete loss of the basic fibril geometry with the emergence of marked “serrated fibril” morphology. The phenotype of the double-KO animal mimics directly the rare progeroid variant of human Ehlers-Danlos syndrome (EDS), in which skin fragility, progeroid changes in the skin (reduced hypodermis), and osteopenia concur as a result of impaired glycosaminoglycan (GAG) linking to bgn and dcn core proteins. Our data show that changes in collagen fibril morphology reminiscent of those occurring in the varied spectrum of human EDS are induced by both bgn deficiency and dcn deficiency in mice. The effects of an individual SLRP deficiency are tissue specific, and the expression of a gross phenotype depends on multiple variables including level of expression of individual SLRPs in different tissues and synergisms between different SLRPs (and likely other macromolecules) in determining matrix structure and functional properties.

Từ khóa


Tài liệu tham khảo

Fisher, 1983, Proteoglycans of developing bone, J Biol Chem, 258, 6588, 10.1016/S0021-9258(18)32453-0

Fisher, 1989, Deduced protein sequence of bone small proteoglycan I (biglycan) shows homology with proteoglycan II (decorin) and several nonconnective tissue proteins in a variety of species, J Biol Chem, 264, 4571, 10.1016/S0021-9258(18)83781-4

Hocking, 1998, Leucine-rich repeat glycoproteins of the extracellular matrix, Matrix Biol, 17, 1, 10.1016/S0945-053X(98)90121-4

Iozzo, 1998, Matrix proteoglycans. From molecular design to cellular function, Ann Rev Biochem, 67, 609, 10.1146/annurev.biochem.67.1.609

Geerkens, 1995, The X-chromosomal human biglycan gene BGN is subject to X inactivation but is transcribed like an X-Y homologous gene, Hum Genet, 96, 44, 10.1007/BF00214185

Hausser, 1994, Selective inactivity of TGF-beta/decorin complexes, FEBS Lett, 353, 243, 10.1016/0014-5793(94)01044-7

Ruoslahti, 1989, Proteoglycans in cell regulation, J Biol Chem, 264, 13369, 10.1016/S0021-9258(18)80001-1

Iozzo, 1999, The biology of the small leucine-rich proteoglycans. Functional network of interactive proteins, J Biol Chem, 274, 18843, 10.1074/jbc.274.27.18843

Vogel, 1987, The effect of proteoglycans on the morphology of collagen fibrils formed in vitro, Coll Relat Res, 7, 105, 10.1016/S0174-173X(87)80002-X

Hedbom, 1993, Binding of fibromodulin and decorin to separate sites on fibrillar collagens, J Biol Chem, 268, 27307, 10.1016/S0021-9258(19)74250-1

Rada, 1993, Regulation of corneal collagen fibrillogenesis in vitro by corneal proteoglycan (lumican and decorin) core proteins, Exp Eye Res, 56, 635, 10.1006/exer.1993.1081

Kresse, 1994, Biosynthesis and interactions of small chondroitin/dermatan sulphate proteoglycans, Eur J Clin Chem Clin Biochem, 32, 259

Schonherr, 1995, Decorin-type I collagen interaction. Presence of separate core protein- binding domains, J Biol Chem, 270, 8877, 10.1074/jbc.270.15.8877

Schonherr, 1995, Interaction of biglycan with type I collagen, J Biol Chem, 270, 2776, 10.1074/jbc.270.6.2776

Kadler, 1996, Collagen fibril formation, Biochem J, 316, 1, 10.1042/bj3160001

Kuc, 1997, Increased diameters of collagen fibrils precipitated in vitro in the presence of decorin from various connective tissues, Connect Tissue Res, 36, 287, 10.3109/03008209709160228

Bianco, 1990, Expression and localization of the two small proteoglycans biglycan and decorin in developing human skeletal and non-skeletal tissues, J Histochem Cytochem, 38, 1549, 10.1177/38.11.2212616

Danielson, 1997, Targeted disruption of decorin leads to abnormal collagen fibril morphology and skin fragility, J Cell Biol, 136, 729, 10.1083/jcb.136.3.729

Chakravarti, 1998, Lumican regulates collagen fibril assembly: Skin fragility and corneal opacity in the absence of lumican, J Cell Biol, 141, 1277, 10.1083/jcb.141.5.1277

Xu, 1998, Targeted disruption of the biglycan gene leads to an osteoporosis-like phenotype in mice, Nat Genet, 20, 78, 10.1038/1746

Bianco, 1984, Basic and “special” stains for plastic sections in bone marrow histopathology, with special reference to May-Grunwald Giemsa and enzyme histochemistry, Basic Appl Histochem, 28, 265

Boyde, 1999, Osteoconduction in large macroporous hydroxyapatite ceramic implants: Evidence for a complementary integration and disintegration mechanism, Bone, 24, 579, 10.1016/S8756-3282(99)00083-6

Boyde, 1995, Standards for mineral quantitation of human bone by analysis of backscattered electron images, Scanning, 17, 6

Howell, 1998, Mean atomic number and backscattered electron coefficient for some materials with low atomic mean number, Scanning, 20, 35, 10.1002/sca.1998.4950200105

Howell, 1998, Monte Carlo simulation of electron backscattering from compounds with low mean atomic number, Scanning, 20, 45, 10.1002/sca.1998.4950200107

Holbrook, 1982, Structural abnormalities in the dermal collagen and elastic matrix from the skin of patients with inherited connective tissue disorders, J Invest Dermatol, 79, 7S, 10.1111/1523-1747.ep12544609

Kobayasi, 1984, Dermal changes in Ehlers-Danlos syndrome, Clin Genet, 25, 477, 10.1111/j.1399-0004.1984.tb00490.x

Steinmann, 1993, Connective Tissue and Its Heritable Disorders. Molecular, Genetic and Medical Aspects, 351

Hausser, 1994, Differential ultrastructural aberrations of collagen fibrils in Ehlers-Danlos syndrome types I-IV as a means of diagnostics and classification, Hum Genet, 93, 394, 10.1007/BF00201664

Mao, 2001, The Ehlers-Danlos syndrome: On beyond collagens, J Clin Invest, 107, 1063, 10.1172/JCI12881

Hardy, 1988, An inherited connective tissue disease in the horse, Lab Invest, 59, 253

Brown, 1993, Abnormalities of collagen fibrils in a rabbit with a connective tissue defect similar to Ehlers-Danlos syndrome, Res Vet Sci, 55, 346, 10.1016/0034-5288(93)90105-O

Birk, 1990, Collagen fibrillogenesis in vitro: Interaction of types I and V collagen regulates fibril diameter, J Cell Sci, 95, 649, 10.1242/jcs.95.4.649

Fleischmajer, 1990, Type I and type III collagen interactions during fibrillogenesis, Ann NY Acad Sci, 580, 161, 10.1111/j.1749-6632.1990.tb17927.x

Svensson, 1999, Fibromodulin-null mice have abnormal collagen fibrils, tissue organization, and altered lumican deposition in tendon, J Biol Chem, 274, 9636, 10.1074/jbc.274.14.9636

Ezura, 2000, Differential expression of lumican and fibromodulin regulate collagen fibrillogenesis in developing mouse tendons, J Cell Biol, 151, 779, 10.1083/jcb.151.4.779

Beighton, 1998, Ehlers-Danlos syndromes revised nosology, Villefranche, 1997. Ehlers-Danlos National Foundation (USA) and Ehlers-Danlos Support Group (UK), Am J Med Genet, 77, 31, 10.1002/(SICI)1096-8628(19980428)77:1<31::AID-AJMG8>3.0.CO;2-O

Ameye, 2000, Biglycan and fibromodulin double knockout mice develop ectopic sesamoid bones and premature osteoarthritis in the knee joint, J Bone Miner Res, 15, S1;185

Dolan, 1998, Assessment of bone in Ehlers Danlos syndrome by ultrasound and densitometry, Ann Rheum Dis, 57, 630, 10.1136/ard.57.10.630

Kresse, 1987, Glycosaminoglycan-free small proteoglycan core protein is secreted by fibroblasts from a patient with a syndrome resembling progeroid, Am J Hum Genet, 41, 436

Quentin, 1990, A genetic defect in the byosinthesis of dermatan sulfate proteoglycan. Galactosyltransferase I deficiency in fibroblasts from a patient with a progeroid syndrome, Proc Natl Acad Sci USA, 87, 1342, 10.1073/pnas.87.4.1342